NASDAQ
PsyBio Therapeutics Corp. (PSYBF) has a eps (diluted) of $-0.04 as of Saturday, December 31, 2022. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.